We developed a human, whole vaginal tissue explant model of ex vivo HIV-1 infection to assess antibody-mediated protection against acute infection, using a panel of HIV-1 Env-specific bnAbs and non-neutralizing mAbs (Fig. 2a), in the presence of tissue resident effector and target cells described above. Here, ERVW-1 is linked to HIV-1 infection.